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Dengue fever is a mosquito-borneviral disease estimated to cause about 230 million infectionsworldwide every
year, of which 25,000 are fatal. Global incidence has risen rapidly in recent decades with some 3.6 billion
people, over half of the world’s population, now at risk, mainly in urban centres of the tropics and subtropics.
Demographic and societal changes, in particular urbanization, globalization, and increased international
travel, are major contributors to the rise in incidence and geographic expansion of dengue infections. Major
research gaps continue to hamper the control of dengue. The European Commission launched a call under the
7th Framework Programme with the title of ‘Comprehensive control of Dengue fever under changing climatic
conditions’. Fourteen partners from several countries in Europe, Asia, and South America formed a
consortium named ‘DengueTools’ to respond to the call to achieve better diagnosis, surveillance, prevention,
and predictive models and improve our understanding of the spread of dengue to previously uninfected regions
(including Europe) in the context of globalization and climate change.
The consortium comprises 12 work packages to address a set of research questions in three areas:
Research area 1: Develop a comprehensive early warning and surveillance system that has predictive capability
for epidemic dengue and benefits from novel tools for laboratory diagnosis and vector monitoring.
Research area 2: Develop novel strategies to prevent dengue in children.
Research area 3: Understand and predict the risk of global spread of dengue, in particular the risk of
introduction and establishment in Europe, within the context of parameters of vectorial capacity, global
mobility, and climate change.
In this paper, we report on the rationale and specific studyobjectives of ‘DengueTools’. DengueTools is funded
under the Health theme of the Seventh Framework Programme of the European Community, Grant
Agreement Number: 282589 Dengue Tools.
Keywords: dengue; dengue control; dengue diagnostics; economic evaluation; entomology; climate change; early warning
systems; risk mapping; surveillance; globalization
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D
engue is the most important arboviral disease of
humans (1). Global incidence has risen rapidly
in recent decades. Some 3.6 billion people, half
of the world’s population, are now at risk, mainly in the
urban centers of the tropics and subtropics (1, 2). Global
reports of dengue hemorrhagic fever (DHF) have in-
creased by fivefold in the past 20 years. The World Health
Organization (WHO) estimates that there are 50100
million infections worldwide every year, of which 21,000
are fatal (3). However, these numbers are gross under-
estimates since recent studies suggest that the figures are
much higher, with as many as 230 million infections, tens
of millions of cases of dengue fever (DF), and millions of
cases of DHF (2, 46). The disease is now endemic in
more than 100 countries in Asia, Africa, and the
Americas. The Asia-Pacific region is the most seriously
affected, with increasing number and magnitude of
dengue epidemics and expanding geographical distribu-
tion (7). Dengue inflicts a significant health, economic,
and social burden on the populations of endemic areas.
The number of disability-adjusted life years (DALYs)
worldwide is estimated to range between 528 and 621 per
million population (8). There is no specific treatment for
dengue, but appropriate medical care can save the lives of
patients with DHF.
There are four antigenically distinct dengue viruses
belongingtothegenusFlavivirusofthefamilyFlaviviridae.
Infectionwithoneserotypeconferslong-termimmunityto
that serotype but not to the others. The strain of virus,
secondary infection, age, and host genetics are the most
important risk factors for severe disease, although the
pathogenetic mechanisms remain poorly understood (8).
Dengue viruses are transmitted by mosquitoes of the
genus Aedes, subgenus Stegomyia. The principal vector,
Aedes Stegomyia aegypti, is now well established in much
of the tropical and subtropical world, particularly in
urban areas. It is a domestic species, highly susceptible to
dengue virus infection, feeding preferentially on human
blood during the daytime often taking multiple blood
meals during a single gonotrophic cycle (8). It typically
breeds in clean stagnant water in artificial containers and
is, therefore, well adapted to urban life. A second species,
Aedes Stegoymyia albopictus, is generally considered a
less-effective epidemic vector because, unlike A. aegypti,
it feeds on many animals other than humans and is less
tied to the domestic environment (9). Nevertheless, this
species has transmitted small outbreaks in some regions,
and in recent years, its importance has increased because
of its rapidly expanding range due to global commerce in
used tyres and other containers (10).
Current surveillance systems and control strategies are
clearly insufficient to prevent epidemic dengue in endemic
countries or to prevent its introduction into uninfested
regions (including Europe) (11). For this reason, in 2010,
the European Commission announced a funding call for
the 7th Framework (Box 1). Within this call, we have
focused on better diagnostics, surveillance, and prediction
of dengue introduction into currently uninfected regions.
We formed a consortium of 14 partners based in South
East Asia, South Asia, South America, and various
centers in Europe (Fig. 1). Led and hosted by the
University of Umea ˚ in Sweden, the consortium includes
partners from academic institutions, the Ministry of
Health in Sri Lanka, a research-intensive small to middle
size research enterprise (SME), and two research compa-
nies. Experts in this consortium include physicians,
epidemiologists, mathematical modellers, climate experts,
environmental scientists, laboratories, ecologists, chemi-
cal ecologists, entomologists, and a health economist
Box 1: European Commission, Seventh Framework
programme, FP7 Cooperation  Health
HEALTH.2011.2.3.3-2: Comprehensive control of
dengue fever under changing climatic conditions.
FP7-HEALTH-2011-single-stage.
Research should develop innovative tools for one or more of
the following aspects: better diagnosis, surveillance, devel-
opment of treatment, prevention and vaccination strategies,
prevention, and/or prediction and prevention of the spread of
dengue fever to previously uninfected regions (including
Europe), in the context of climate change. Research may also
include studies on the underlying pathogenesis with respect
to viral and host factors that can predict disease severity and
prepare for further development of new vaccines, antiviral
compounds, and more targeted treatment schemes.
Funding scheme: Specific International Cooperation Action
(SICA) Collaborative Project (small- or medium-scale focused
research project) target regions: Latin America and/or Asia.
SICA aims to bring about the balanced participation of third
countries in collaboration with European partners.
Expected impact: Better tools, and the use thereof, for
improved comprehensive control of dengue fever at a global
level. Participation from both SICA target regions and SMEs in
the projects should help ensuring innovation and exploitation
of the results in this area/topic. The degree of such
participation will be considered during the evaluation.
Source: http://ec.europa.eu/research/health/infectious-
diseases/emerging-epidemics/call-for-proposals_en.html
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Citation: Glob Health Action 2012, 5: 17273 - DOI: 10.3402/gha.v5i0.17273(Table 1). The strength of the consortium lies in the
breadth of expertise and the international network of
partners from which it draws to address the challenging
tasks of the 7th European Union Framework. The
acronym of our 4-year project is ‘DengueTools’.
Rationale and research objectives
DengueTools created 12 work packages (Fig. 2) to
address gaps related to (1) surveillance, (2) control, and
(3) risk of introduction of dengue to uninfected areas.
Fig. 1. Geographic distribution of the 14 DengueTools consortium partners.
Table 1. Integrated expertise of members the consortium
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Data managementpopulation studies ª
Disease surveillance ªª ª
Entomology ª ªªª ª ª ª
Vector control ªª ª
GIS and remote sensing ª
Climate change ªª
Modeling ªª ª
Clinical/community trials ªª
Clinical management ªª
Viral genetic studies ªª ª
Diagnostic assays ªª ª
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summarized in Box 2.
Research area 1
Main research objective
Develop a comprehensive early warning surveillance
system that has predictive capability for epidemic dengue
using novel tools for laboratory diagnosis and vector
monitoring.
Rationale
The dramatic global spread and increased frequency and
magnitude of epidemic DF/DHF in the past 40 years
underscore the critical need for more effective surveil-
lance, prevention, and control of this disease. Most
endemic countries do not have adequate surveillance to
monitor dengue disease. The main purpose of surveillance
is to provide information on risk assessment, epidemic
response, and programme evaluation and to allow timely
action to prevent or control dengue epidemic.
The risk of epidemic dengue transmission is deter-
mined by a combination of factors that include the level
of herd immunity to virus serotypes; virulence character-
istics of the virus strain; survival, feeding behavior, and
abundance of Aedes mosquitoes; weather; and socio-
economic factors and human population density, dis-
tribution, and movement (12). Several potential
predictive indicators for outbreaks have been described
but require further study (13, 14).
The appearance of a new dengue serotype can be used
as an early warning sign, although it does not always
predict the occurrence of an immediate epidemic (15).
Fig. 2. Twelve work packages (WP) and their interconnectedness around the three research areas. Work package 12 handles the
management and dissemination of all work packages (not included in this ﬁgure).
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serotype and outbreak occurrence remain unknown but
the time lag may vary from 1 to 2 months to years.
The evolution of dengue viruses may have a major
impact on their epidemic potential, virulence for humans,
and geographic spread around the world (16). Currently,
dengue viruses can be classified as being of epidemiolo-
gically low, medium, or high impact; i.e. some viruses
may remain in sylvatic cycles with little or no transmis-
sibility to humans; others are associated with DF only,
and some strains have the potential to cause major
epidemics and more severe DHF and DSS (1618).
Phylogenetic and epidemiological analyses suggest that
the genotypes and subtypes with greater epidemic poten-
tial regularly displace those that have lower epidemic
potential. Nevertheless, a more complete understanding
of the evolution and epidemiology of dengue viruses,
particularly with respect to predicting epidemics of more
severe disease, requires large-scale prospective studies
that compare phenotypic expression with genetic changes
in the viruses (18, 19).
The major components of dengue surveillance include
monitoring the disease, mosquito vectors, and environ-
mental and social risks (3). A Cochrane review of the
application of tools for dengue outbreak prediction/
detection and trend monitoring in surveillance systems
highlighted the lack of evidence on the most feasible and
sustainable surveillance approach (14). Prospective stu-
dies are needed to better define the most appropriate and
cost-effective dengue surveillance system and to identify
triggers for dengue emergency response. For surveillance
to effectively provide early warning for epidemic trans-
mission, it must be active, laboratory based, and com-
prehensive in its coverage of the spectrum of clinical
illness, the catchment area, and the factors that influence
transmission dynamics. We propose to study individual
and combined indicators for outbreak detection and
prediction to assess the relative value of each. Particular
attention will be given to the role of viral factors. These
data will be used to develop models capable of predicting
epidemics, thereby providing more precise information on
risk areas to target control activities.
Finally, given the limited resources in most dengue
endemic countries, it is crucial to identify the most
sensitive, specific, and cost-effective signal or combina-
tion of signals for an early warning system that would
allow timely institution of control measures. Our con-
sortium will address the affordability and sustainability of
an active sentinel surveillance system, an important issue
for policy makers.
Diagnostic assays
The lack of laboratory capacity and capability and the
availabilityofaffordable,sensitive,andspecificdiagnostics
contribute to the poor surveillance in resource-limited
countries. Accurate laboratory diagnosis of
dengue patients is important to the individual patient and
for surveillance and control efforts. An accurate
point-of-care diagnosis can assist in patient management,
prevent unnecessary and possibly expensive antibiotic
usage, facilitate triage of febrile patients into appropriate
clinics, and reduce health care utilization costs. We
propose to develop two potential diagnostic assays, by
using the recombinase polymerase amplification technol-
ogy and the loop-mediated isothermal amplification
approach.
Furthermore, new rapid, inexpensive, and operation-
ally amenable methodologies are needed for vector
Box 2: Research gaps identiﬁed by the DengueTools
consortium
Gaps in dengue surveillance:
1. Lack of understanding of individual or combined roles
of viral, entomological, ecological, environmental, and
climate factors that influence dengue transmission
dynamics and their respective outbreak predictive
capability
2. Lack of evidence on the most feasible, sustainable, and
cost-effective approach to integrated surveillance
3. Lack of sensitive and specific early diagnostic assays for
field use (inexpensive, rapid results, point-of-care, and
portable)
4. Lack of sensitive, reliable, and simple field methods for
vector surveillance
Gaps in the prevention and control of dengue:
1. Lack of effective control strategies to protect children
2. Lack of evaluation of current control methods of vectors,
in particular the differences in the control of A. aegypti and
A. albopictus, which have implications for vector control
efforts in Europe.
Gaps in understanding the risk of introduction of dengue
to non-infected areas, including Europe:
1. Insufficient data on the magnitude and trends of
importation and virus evolution over time and by
geographic origin
2. Poor understanding of vector density, preferred breeding
sites, and vectorial capacity of vectors in temperate
climates that are needed for predictive models under
changing climate conditions
3. Lack of predictive models for the risk of establishment of
dengue in uninfected regions (in particular Europe), taking
into account global travel networks and climate change
DengueTools
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monitoring, including the use of attractants to increase
trap efficacy in the field. Available adult traps vary in
cost, species-specificity, and capture rate. For example,
BG-Sentinel traps are expensive and require electrical
power, which restrict the number of such traps than can
be deployed. Different applications may have different
requirements in terms of preferred specificity for different
mosquito species, or even sex or age of mosquitoes within
a given species; so, there may not be one optimal trap for
all purposes. We will investigate both host kairomones
(20, 21) and oviposition attractants (2226) in different
trap formats. We will test putative attractants by using
laboratory-based behavioral bioassays to evaluate and
shortlist candidate compounds for subsequent field
evaluation of efficacy and persistence in both adult and
ovitraps.
Deliverables for research area 1
1. Develop a comprehensive, early warning, labora-
tory-based sentinel disease surveillance system and
determine the most useful and cost-effective pre-
dictive factors for epidemic dengue;
2. Develop predictive models in particular signature
forecasting and a flagging system;
3. Study how viral evolution influences the virulence
and epidemic potential of dengue viruses;
4. Develop and validate novel diagnostic assays for
point-of-care use;
5. Develop improved field devices and attractants for
vector monitoring;
6. Develop novel assays for virus detection and char-
acterization in Aedes mosquitoes;
7. Study entomological and environmental indicators
that may influence dengue transmission dynamics;
8. Develop geospatial modeling and risk maps;
9. Evaluate the predictive capability of climate vari-
ables (weather variability) and their operational
utility for surveillance;
10. Relate the costs of dengue surveillance and preven-
tion to their effect on the burden of the disease;
11. Engage policy makers on the sustainability of an
integrated surveillance system.
Research area 2
Main research objective
Develop novel strategies to prevent dengue in children.
Rationale
In the absence of specific antiviral therapy and vaccina-
tion, other prevention strategies need to be developed.
Vector control in itself has had poor results to date.
Insecticide-treated fabrics have emerged as a key compo-
nent of arboviral disease control efforts. Insecticide-
treated bed nets (ITNs) have been shown to be a
successful intervention for the control of malaria (27).
The efficacy of ITNs in reducing malaria transmission is
related to the night biting activities of anopheline
mosquitoes, but their use may have little or no impact
on dengue incidence because Aedes species have daytime
feeding patterns. However, window curtains and domestic
water container covers treated with insecticide can reduce
densities of dengue vectors and potentially affect dengue
transmission (28).
Additional novel approaches using insecticide-treated
materials need to be evaluated for the control of dengue.
Personal clothing would potentially be an excellent target
because clothes are worn during day times. There have
been a number of programs that have applied insecticides
to personal clothing, but this has been limited to military
and recreational markets.
There is an urgent need for integrated and comple-
mentary population-based strategies to protect vulner-
able children. Children carry the main burden of
morbidity and mortality caused by dengue (3, 29).
Dengue is often more severe in children, and children
have a higher risk for developing DHF (3, 30). Infection
in children causes large disruptions in schooling and
parental wage earning that in turn has direct impacts on
nutrition and overall family health (31). For example, in
Northern Thailand, it has been estimated that dengue
contributes 465.3 DALYs per million population per
year among school-aged children, which accounts for
15% of all DALYs loss from febrile illness in this age
group (32). Over the past 40 years, 65% of reported
cases in Thailand were confined to the 514 years age
group. Because children of this age group spend a
considerable amount of their day at school, it is likely
that schools are primary sites for exposure to the
daytime biting Aedes mosquitoes. Schools should there-
fore be a key target for control. From a pragmatic point
of view, schools would be an easier target in comparison
to dispersed populations. School uniforms are a cultural
norm in most developing countries and are worn
throughout the day on an almost daily basis. We
hypothesize that impregnated school uniforms may
reduce the incidence of dengue in school-aged children
(33). To test our hypothesis, we will conduct a commu-
nity-based randomized controlled trial of the efficacy of
impregnated school uniforms on the incidence of dengue
in school-aged children. Furthermore, we will test the
repellency effect of school uniforms in different sizes and
forms and with different impregnation methods in a
laboratory setting.
Annelies Wilder-Smith et al.
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1. Determine the efficacy of impregnated school uni-
forms in reducing the incidence of dengue in school-
aged children;
2. Determine the protection efficacy of school uni-
forms impregnated with repellent under different
laboratory scenarios;
3. Develop a cost-effectiveness framework and under-
take an economic evaluation of the school-based
preventive intervention;
4. Produce policy briefs and engage with policy makers
to ensure the scalability of such school-based inter-
vention programs, should the trial show efficacy.
Research area 3
Main research objective
Contribute to the understanding and predicting the risk
of spread of dengue, in particular the risk of introduction
and establishment in Europe, within the context vector
competence, human mobility, and climate change.
Rationale
Dengue is the second most common cause of fever in
returning international travellers, and the frequency of
importation of dengue into currently non-endemic areas
via travellers is increasing (34). There have been small
outbreaks of dengue in Texas, USA, since 1980, all
associated with increased transmission and importation
from Mexico. In 2001, a small outbreak transmitted by A.
albopictus, the first in 56 years, occurred in Hawaii. In
2009 and 2010, small outbreaks transmitted by A. aegypti
occurred in Key West, Florida. Also, in 2010, the first
authochthonous transmission of dengue occurred in
Europe since before World War II: two cases in France
and one in Croatia (www.eurosurveillance.org). A. albo-
pictus is the only vector present in Europe with a wide
and increasing distribution in many countries.
It is important to determine the risk of dengue
becoming endemic in Europe. A. albopictus, although
typically not an effective epidemic vector of dengue (9), is
capable of transmitting dengue, and it is further spread-
ing northward from countries bordering the Mediterra-
nean. The risk of infection depends on vectorial capacity
and viral replication rate in a temperate climate. The key
question, therefore, is whether the presence of this vector
is conducive to epidemic transmission in the event of
importations into Europe.
Deliverables for research area 3
1. Monitor dengue importation into Europe;
2. Produce phylogenetic trees of imported dengue
viruses to Europe using Bayesian modeling;
3. Compare the clinical manifestations and usefulness
of the 2009 WHO dengue classification schemes in
travellers (non-endemic populations) versus endemic
populations (Sri Lanka);
4. Describe the breeding sites for A. albopictus in
Southern France;
5. Determine the vectorial capacity of A. albopictus in
a temperate climate;
6. Assess the impact of ultralow volume (ULV) spacing
spraying on populations of adult A. albopictus in
southern France;
7. Develop predictive models that integrate vector
competence, vectorial capacity, and force of infec-
tion with global human mobility to assess the risk of
epidemic transmission following the introduction of
dengue viruses;
8. Produce interactive web-based tools on the risk of
global spread of dengue, particularly to Europe.
Conclusions
Dengue fever is within the scope of the global health
priorities. DengueTools is designed to address this
priority. This cooperative and multidisciplinary project
is also designed to improve the potential for new know-
ledge generation by integrating research groups with
different scientific backgrounds, research centers from
different European countries, and fostering research links
between the North and South.
Effective surveillance and control for dengue is lacking.
We will coordinate and facilitate one of the largest
prospective integrated surveillance programs ever done
in an endemic setting, in an attempt to find an answer to
the most feasible strategy that will reliably predict new
outbreaks and provide time-sensitive information for
containment. Furthermore, we will attempt to develop
novel inexpensive diagnostic tools, both for human
diagnostics as well as for vector monitoring that will
enhance an integrated surveillance system. Given the
limited resources in many dengue endemic countries, it is
of utmost importance to relate the costs of novel
strategies for dengue surveillance and prevention to their
effect on the burden of the disease. We will evaluate the
economic value and benefit of each component of the
integrated surveillance.
A second research area will focus on innovative
strategies to reduce dengue infections in children by
targeting schools. Reducing the incidence of dengue in
school children will not only reduce morbidity and
mortality but also reduce the number of school days
lost, increase school performance, and reduce the
economic burden on parents.
Dengue carries the risk of further geographic expan-
sion and introduction into uninfected areas, including
Europe. We will assess the risk of introduction of dengue
under different future scenarios (such as climate change
DengueTools
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into Europe and develop predictive models to enhance
Europe’s preparedness for future dengue epidemics.
During the course of these 4 years, we will evaluate
several novel tools and strategies that will have the
potential to be scaled-up and, therefore, would need
translation into public policy. Our consortium includes a
health economist and policy analyst who will translate
our research findings into evidence-informed policy
making. Engagement with stakeholders and policy
makers will start early in the project to ensure the
potential for scaling up our recommendations.
DengueTools is funded under the Health theme of the
Seventh Framework Programme of the European
Community, Grant Agreement Number: 282589 Dengue
Tools.
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